Primary cicatricial alopecias

References

• Olsen EA, Bergfeld WF, Cotsarelis G et al. Summary of North American Hair Research Society (NAHRS)-sponsored workshop on cicatricial alopecia, Duke University Medical Center, February 10 and 11, 2001. J. Am. Acad. Dermatol.48(1), 103–110 (2003).
   PubMedGoogle Scholar
• McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum.38(9), 1260–1270 (1995).
   PubMed Web of Science ®Google Scholar
• Wilson CL, Burge SM, Dean D, Dawber RP. Scarring alopecia in discoid lupus erythematosus. Br. J. Dermatol.126(4), 307–314 (1992).
   PubMed Web of Science ®Google Scholar
• Callen JP. Chronic cutaneous lupus erythematosus. Clinical, laboratory, therapeutic, and prognostic examination of 62 patients. Arch. Dermatol.118(6), 412–416 (1982).
   PubMedGoogle Scholar
• Tan E, Martinka M, Ball N, Shapiro J. Primary cicatricial alopecias: clinicopathology of 112 cases. J. Am. Acad. Dermatol.50(1), 25–32 (2004).
   PubMed Web of Science ®Google Scholar
• Kuhn A, Bijl M. Pathogenesis of cutaneous lupus erythematosus. Lupus17(5), 389–393 (2008).
   PubMed Web of Science ®Google Scholar
• Wenzel J, Zahn S, Mikus S, Wiechert A, Bieber T, Tuting T. The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets. Br. J. Dermatol.157(4), 752–757 (2007).
   PubMed Web of Science ®Google Scholar
• Wenzel J, Tuting T. Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches. Exp. Dermatol.16(5), 454–463 (2007).
   PubMed Web of Science ®Google Scholar
• Franz B, Fritzsching B, Riehl A et al. Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus. Arthritis Rheum.56(6), 1910–1920 (2007).
   PubMed Web of Science ®Google Scholar
• Chieregato C, Barba A, Zini A, Peroni A, Magnanini M, Rosina P. Discoid lupus erythematosus: clinical and pathological study of 24 patients. J. Eur. Acad. Dermatol. Venereol.18(1), 113 (2004).
   PubMedGoogle Scholar
• Fabbri P, Amato L, Chiarini C, Moretti S, Massi D. Scarring alopecia in discoid lupus erythematosus: a clinical, histopathologic and immunopathologic study. Lupus13(6), 455–462 (2004).
   PubMed Web of Science ®Google Scholar
• Rothfield N, Sontheimer RD, Bernstein M. Lupus erythematosus: systemic and cutaneous manifestations. Clin. Dermatol.24(5), 348–362 (2006).
   PubMed Web of Science ®Google Scholar
• Donnelly AM, Halbert AR, Rohr JB. Discoid lupus erythematosus. Australas J. Dermatol.36(1), 3–10; quiz 11–12(1995).
   PubMedGoogle Scholar
• Callen JP. Cutaneous lupus erythematosus: a personal approach to management. Australas J. Dermatol.47(1), 13–27 (2006).
   PubMed Web of Science ®Google Scholar
• Ma D, Dai G, Guo C. [Carcinoma of the lips developing in discoid lupus erythematosus.] Zhonghua Kou Qiang Yi Xue Za Zhi.34(1), 13–15 (1999).
   PubMedGoogle Scholar
• Ee HL, Ng PP, Tan SH, Goh CL. Squamous cell carcinoma developing in two Chinese patients with chronic discoid lupus erythematosus: the need for continued surveillance. Clin. Exp. Dermatol.31(4), 542–544 (2006).
   PubMed Web of Science ®Google Scholar
• Whiting DA. Cicatricial alopecia: clinico–pathological findings and treatment. Clin. Dermatol.19(2), 211–225 (2001).
   PubMed Web of Science ®Google Scholar
• Templeton SF, Solomon AR. Scarring alopecia: a classification based on microscopic criteria. J. Cutan. Pathol.21(2), 97–109 (1994).
   PubMed Web of Science ®Google Scholar
• Kossard S. Lymphocytic mediated alopecia: histological classification by pattern analysis. Clin. Dermatol.19(2), 201–210 (2001).
   PubMed Web of Science ®Google Scholar
• Headington JT. Cicatricial alopecia. Dermatol. Clin.14(4), 773–782 (1996).
   PubMed Web of Science ®Google Scholar
• Sperling LC. Scarring alopecia and the dermatopathologist. J. Cutan. Pathol.28(7), 333–342 (2001).
   PubMed Web of Science ®Google Scholar
• Shahidullah M, Lee YS, Khor CJ, Ratnam KV. Chronic discoid lupus erythematosus: an immunopathological and electron microscopic study. Ann. Acad. Med. Singapore24(6), 789–792 (1995).
   PubMedGoogle Scholar
• Trachsler S, Trueb RM. Value of direct immunofluorescence for differential diagnosis of cicatricial alopecia. Dermatology211(2), 98–102 (2005).
   PubMed Web of Science ®Google Scholar
• Crowson AN, Magro C. The cutaneous pathology of lupus erythematosus: a review. J. Cutan. Pathol.28(1), 1–23 (2001).
   PubMed Web of Science ®Google Scholar
• Dahl MV. Usefulness of direct immunofluorescence in patients with lupus erythematosus. Arch. Dermatol.119(12), 1010–1017 (1983).
   PubMedGoogle Scholar
• Tebbe B, Mansmann U, Wollina U et al. Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients. Acta Derm. Venereol.77(4), 305–308 (1997).
   PubMed Web of Science ®Google Scholar
• Sanders CJ, Van Weelden H, Kazzaz GA, Sigurdsson V, Toonstra J, Bruijnzeel-Koomen CA. Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol. Br. J. Dermatol.149(1), 131–137 (2003).
   PubMed Web of Science ®Google Scholar
• Roenigk HH Jr, Martin JS, Eichorn P, Gilliam JN. Discoid lupus erythematosus. Diagnostic features and evaluation of topical corticosteroid therapy. Cutis25(3), 281–285 (1980).
   PubMed Web of Science ®Google Scholar
• Callen JP. Intralesional triamcinolone is effective for discoid lupus erythematosus of the palms and soles. J. Rheumatol.12(3), 630–633 (1985).
   PubMed Web of Science ®Google Scholar
• Gunasekera V, Jayaram H, Kashani S, Toma NM, Olver JM. Refractory discoid lupus erythematosis of the eyelid successfully treated with intra-lesional triamcinolone. Eye (Lond.)22(9), 1205–1206 (2008).
   PubMed Web of Science ®Google Scholar
• Edwards KR, Burke WA. Treatment of localized discoid lupus erythematosus with tazarotene. J. Am. Acad. Dermatol.41(6), 1049–1050 (1999).
   PubMed Web of Science ®Google Scholar
• Barikbin B, Givrad S, Yousefi M, Eskandari F. Pimecrolimus 1% cream versus β-methasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot study. Clin. Exp. Dermatol.34(7), 776–780 (2009).
   PubMed Web of Science ®Google Scholar
• Tzellos TG, Kouvelas D. Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation. Eur. J. Clin. Pharmacol.64(4), 337–341 (2008).
   PubMed Web of Science ®Google Scholar
• Gul U, Gonul M, Cakmak SK, Kilic A, Demiriz M. A case of generalized discoid lupus erythematosus: successful treatment with imiquimod cream 5%. Adv. Ther.23(5), 787–792 (2006).
   PubMed Web of Science ®Google Scholar
• Gerdsen R, Wenzel J, Uerlich M, Bieber T, Petrow W. Successful treatment of chronic discoid lupus erythematosus of the scalp with imiquimod. Dermatology205(4), 416–418 (2002).
   PubMedGoogle Scholar
• Ruzicka T, Sommerburg C, Goerz G, Kind P, Mensing H. Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine. Br. J. Dermatol.127(5), 513–518 (1992).
   PubMed Web of Science ®Google Scholar
• Jewell ML, McCauliffe DP. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. J. Am. Acad. Dermatol.42(6), 983–987 (2000).
   PubMed Web of Science ®Google Scholar
• Wozniacka A, McCauliffe DP. Optimal use of antimalarials in treating cutaneous lupus erythematosus. Am. J. Clin. Dermatol.6(1), 1–11 (2005).
   PubMed Web of Science ®Google Scholar
• Rahman P, Gladman DD, Urowitz MB. Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus. J. Rheumatol.25(9), 1716–1719 (1998).
   PubMed Web of Science ®Google Scholar
• Shornick JK, Formica N, Parke AL. Isotretinoin for refractory lupus erythematosus. J. Am. Acad. Dermatol.24(1), 49–52 (1991).
   PubMed Web of Science ®Google Scholar
• Vena GA, Coviello C, Angelini G. [Use of oral isotretinoin in the treatment of cutaneous lupus erythematosus.] G. Ital. Dermatol. Venereol.124(6), 311–315 (1989).
   PubMedGoogle Scholar
• Dalziel K, Going G, Cartwright PH, Marks R, Beveridge GW, Rowell NR. Treatment of chronic discoid lupus erythematosus with an oral gold compound (auranofin). Br. J. Dermatol.115(2), 211–216 (1986).
   PubMed Web of Science ®Google Scholar
• Lindskov R, Reymann F. Dapsone in the treatment of cutaneous lupus erythematosus. Dermatologica172(4), 214–217 (1986).
   PubMedGoogle Scholar
• Neri R, Mosca M, Bernacchi E, Bombardieri S. A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with dapsone. Lupus8(3), 240–243 (1999).
   PubMed Web of Science ®Google Scholar
• Wenzel J, Brahler S, Bauer R, Bieber T, Tuting T. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients. Br. J. Dermatol.153(1), 157–162 (2005).
   PubMed Web of Science ®Google Scholar
• Huber A, Tuting T, Bauer R, Bieber T, Wenzel J. Methotrexate treatment in cutaneous lupus erythematosus: subcutaneous application is as effective as intravenous administration. Br. J. Dermatol.155(4), 861–862 (2006).
   PubMed Web of Science ®Google Scholar
• Goyal S, Nousari HC. Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil. J. Am. Acad. Dermatol.45(1), 142–144 (2001).
   PubMed Web of Science ®Google Scholar
• Ashinoff R, Werth VP, Franks AG Jr. Resistant discoid lupus erythematosus of palms and soles: successful treatment with azathioprine. J. Am. Acad. Dermatol.19(5 Pt 2), 961–965 (1988).
   PubMed Web of Science ®Google Scholar
• Shehade S. Successful treatment of generalized discoid skin lesions with azathioprine. Arch. Dermatol.122(4), 376–377 (1986).
   PubMedGoogle Scholar
• Brocard A, Barbarot S, Milpied B, Stalder JF. [Thalidomide in the treatment of chronic discoid lupus erythematosus]. Ann. Dermatol. Venereol.132(11 Pt 1), 853–856 (2005).
   PubMed Web of Science ®Google Scholar
• Cuadrado MJ, Karim Y, Sanna G, Smith E, Khamashta MA, Hughes GR. Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens. Am. J. Med.118(3), 246–450 (2005).
   PubMed Web of Science ®Google Scholar
• Mobini N, Tam S, Kamino H. Possible role of the bulge region in the pathogenesis of inflammatory scarring alopecia: lichen planopilaris as the prototype. J. Cutan. Pathol.32(10), 675–679 (2005).
   PubMed Web of Science ®Google Scholar
• DeRossi SS, Ciarrocca KN. Lichen planus, lichenoid drug reactions, and lichenoid mucositis. Dent. Clin. North Am.49(1), 77–89 (2005).
   PubMedGoogle Scholar
• Brudy L, Janier M, Reboul D, Baviera E, Bonvalet D, Daniel F. [Erosive lichen of the scalp]. Ann. Dermatol. Venereol.124(10), 703–706 (1997).
   PubMed Web of Science ®Google Scholar
• Moravedge H, Salamat A. Dermatitis herpetiformis in association with lichen planopilaris. J. Am. Acad. Dermatol.46(3), 467–468 (2002).
   PubMedGoogle Scholar
• Rosina P, Chieregato C, Magnanini M, Barba A. Lichen planopilaris and autoimmune thyroiditis. J. Eur. Acad. Dermatol. Venereol.16(6), 648–649 (2002).
   PubMed Web of Science ®Google Scholar
• Karnik P, Tekeste Z, McCormick TS et al. Hair follicle stem cell-specific PPARg deletion causes scarring alopecia. J. Invest. Dermatol.129(5), 1243–1257 (2009).
   PubMed Web of Science ®Google Scholar
• Chieregato C, Zini A, Barba A, Magnanini M, Rosina P. Lichen planopilaris: report of 30 cases and review of the literature. Int. J. Dermatol.42(5), 342–345 (2003).
   PubMed Web of Science ®Google Scholar
• Eisen D. The evaluation of cutaneous, genital, scalp, nail, esophageal, and ocular involvement in patients with oral lichen planus. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.88(4), 431–436 (1999).
   PubMed Web of Science ®Google Scholar
• Mehregan DA, Van Hale HM, Muller SA. Lichen planopilaris: clinical and pathologic study of forty-five patients. J. Am. Acad. Dermatol.27(6 Pt 1), 935–942 (1992).
   PubMed Web of Science ®Google Scholar
• Kossard S, Lee MS, Wilkinson B. Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris. J. Am. Acad. Dermatol.36(1), 59–66 (1997).
   PubMed Web of Science ®Google Scholar
• Moreno-Ramirez D, Camacho Martinez F. Frontal fibrosing alopecia: a survey in 16 patients. J. Eur. Acad. Dermatol. Venereol.19(6), 700–705 (2005).
   PubMed Web of Science ®Google Scholar
• Ghislain PD, Van Eeckhout P, Ghislain E. Lassueur–Graham–Little–Piccardi syndrome: a 20-year follow-up. Dermatology206(4), 391–392 (2003).
   PubMed Web of Science ®Google Scholar
• Srivastava M, Mikkilineni R, Konstadt J. Lassueur–Graham–Little–Piccardi syndrome. Dermatol. Online J.13(1), 12 (2007).
   PubMedGoogle Scholar
• Bianchi L, Paro Vidolin A, Piemonte P, Carboni I, Chimenti S. Graham–Little–Piccardi–Lassueur syndrome: effective treatment with cyclosporin A. Clin. Exp. Dermatol.26(6), 518–520 (2001).
   PubMed Web of Science ®Google Scholar
• Tandon YK, Somani N, Cevasco NC, Bergfeld WF. A histologic review of 27 patients with lichen planopilaris. J. Am. Acad. Dermatol.59(1), 91–98 (2008).
   PubMed Web of Science ®Google Scholar
• Annessi G, Lombardo G, Gobello T, Puddu P. A clinicopathologic study of scarring alopecia due to lichen planus: comparison with scarring alopecia in discoid lupus erythematosus and pseudopelade. Am. J. Dermatopathol.21(4), 324–331 (1999).
   PubMed Web of Science ®Google Scholar
• Elston DM, McCollough ML, Warschaw KE, Bergfeld WF. Elastic tissue in scars and alopecia. J. Cutan. Pathol.27(3), 147–152 (2000).
   PubMed Web of Science ®Google Scholar
• Gimenez-Garcia R, Perez-Castrillon JL. Lichen planus and hepatitis C virus infection. J. Eur. Acad. Dermatol. Venereol.17(3), 291–295 (2003).
   PubMed Web of Science ®Google Scholar
• Cevasco NC, Bergfeld WF, Remzi BK, de Knott HR. A case-series of 29 patients with lichen planopilaris: the Cleveland Clinic Foundation experience on evaluation, diagnosis, and treatment. J. Am. Acad. Dermatol.57(1), 47–53 (2007).
   PubMed Web of Science ®Google Scholar
• Spencer LA, Hawryluk EB, English JC 3rd. Lichen planopilaris: retrospective study and stepwise therapeutic approach. Arch. Dermatol.145(3), 333–334 (2009).
   PubMedGoogle Scholar
• Price VH. The medical treatment of cicatricial alopecia. Semin. Cutan. Med. Surg.25(1), 56–59 (2006).
   PubMed Web of Science ®Google Scholar
• Ott F, Bollag W, Geiger JM. Efficacy of oral low-dose tretinoin (all-trans-retinoic acid) in lichen planus. Dermatology192(4), 334–346 (1996).
   PubMed Web of Science ®Google Scholar
• Cribier B, Frances C, Chosidow O. Treatment of lichen planus. An evidence-based medicine analysis of efficacy. Arch. Dermatol.134(12), 1521–1530 (1998).
   PubMed Web of Science ®Google Scholar
• Naylor GD. Treating erosive lichen planus with griseofulvin: a report of four cases. Quintessence Int.21(12), 943–947 (1990).
   PubMedGoogle Scholar
• Mirmirani P, Willey A, Price VH. Short course of oral cyclosporine in lichen planopilaris. J. Am. Acad. Dermatol.49(4), 667–671 (2003).
   PubMed Web of Science ®Google Scholar
• Tursen U, Api H, Kaya T, Ikizoglu G. Treatment of lichen planopilaris with mycophenolate mofetil. Dermatol. Online J.10(1), 24 (2004).
   PubMedGoogle Scholar
• Tosti A, Piraccini BM, Iorizzo M, Misciali C. Frontal fibrosing alopecia in postmenopausal women. J. Am. Acad. Dermatol.52(1), 55–60 (2005).
   PubMed Web of Science ®Google Scholar
• Katoulis A, Georgala, Bozi E, Papadavid E, Kalogeromitros D, Stavrianeas N. Frontal fibrosing alopecia: treatment with oral dutasteride and topical pimecrolimus. J. Eur. Acad. Dermatol. Venereol.23(5), 580–582 (2009).
   PubMed Web of Science ®Google Scholar
• Alzolibani AA, Kang H, Otberg N, Shapiro J. Pseudopelade of Brocq. Dermatol.Ther.21(4), 257–263 (2008).
   PubMed Web of Science ®Google Scholar
• Pincelli C, Girolomoni G, Benassi L. Pseudopelade of Brocq: an immunologically mediated disease? Dermatologica174(1), 49–50 (1987).
   PubMedGoogle Scholar
• Sullivan JR, Kossard S. Acquired scalp alopecia. Part I: a review. Australas J. Dermatol.39(4), 207–219 (1998).
   PubMedGoogle Scholar
• Kostler E, Hubl W, Seebacher C. [PCR detected Borrelia burgdorferi DNA in a tissue sample in pseudopelade Brocq.] Hautarzt50(12), 897 (1999).
   PubMed Web of Science ®Google Scholar
• Yu M, Bell RH, Ross EK et al. Lichen planopilaris and pseudopelade of Brocq involve distinct disease associated gene expression patterns by microarray. J. Dermatol. Sci.57(1), 27–36 (2010).
   PubMed Web of Science ®Google Scholar
• Wiseman MC, Shapiro J. Scarring alopecia. J. Cutan. Med. Surg.3(Suppl. 3), S45–S48 (1999).
   Google Scholar
• Ronchese F. Pseudopelade. Arch. Dermatol.82, 336–343 (1960).
   PubMedGoogle Scholar
• Amato L, Massi D, Berti S, Moretti S, Fabbri P. A multiparametric approach is essential to define different clinicopathological entities within pseudopelade of Brocq. Br. J. Dermatol.146(3), 532–533 (2002).
   PubMed Web of Science ®Google Scholar
• Nayar M, Schomberg K, Dawber RP, Millard PR. A clinicopathological study of scarring alopecia. Br. J. Dermatol.128(5), 533–536 (1993).
   PubMed Web of Science ®Google Scholar
• Braun-Falco O, Imai S, Schmoeckel C, Steger O, Bergner T. Pseudopelade of Brocq. Dermatologica172(1), 18–23 (1986).
   PubMedGoogle Scholar
• Pinkus H. Differential patterns of elastic fibers in scarring and non-scarring alopecias. J. Cutan. Pathol.5(3), 93–104 (1978).
   PubMed Web of Science ®Google Scholar
• Gathers RC, Jankowski M, Eide M, Lim HW. Hair grooming practices and central centrifugal cicatricial alopecia. J. Am. Acad. Dermatol.60(4), 574–578 (2009).
   PubMed Web of Science ®Google Scholar
• Whiting DA, Olsen EA. Central centrifugal cicatricial alopecia. Dermatol. Ther.21(4), 268–278 (2008).
   PubMed Web of Science ®Google Scholar
• Sperling LC, Sau P. The follicular degeneration syndrome in black patients. ‘Hot comb alopecia’ revisited and revised. Arch. Dermatol.128(1), 68–74 (1992).
   PubMedGoogle Scholar
• Mahe A. Scarring alopecia and ethnicity. Arch. Dermatol.137(3), 374–375 (2001).
   PubMedGoogle Scholar
• Callender VD, McMichael AJ, Cohen GF. Medical and surgical therapies for alopecias in black women. Dermatol. Ther.17(2), 164–176 (2004).
   PubMedGoogle Scholar
• Sperling LC, Skelton HG 3rd, Smith KJ, Sau P, Friedman K. Follicular degeneration syndrome in men. Arch. Dermatol.130(6), 763–769 (1994).
   PubMedGoogle Scholar
• Gathers RC, Lim HW. Central centrifugal cicatricial alopecia: past, present, and future. J. Am. Acad. Dermatol.60(4), 660–668 (2009).
   PubMed Web of Science ®Google Scholar
• Gibson LE, Muller SA, Leiferman KM, Peters MS. Follicular mucinosis: clinical and histopathologic study. J. Am. Acad. Dermatol.20(3), 441–446 (1989).
   PubMed Web of Science ®Google Scholar
• Plotnick H, Abbrecht M. Alopecia mucinosa and lymphoma. Report of two cases and review of literature. Arch. Dermatol.92(2), 137–141 (1965).
   Google Scholar
• Thomson J, Cochran RE. Chronic lymphatic leukemia presenting as atypical rosacea with follicular mucinosis. J. Cutan. Pathol.5(2), 81–87 (1978).
   PubMed Web of Science ®Google Scholar
• Mehregan DA, Gibson LE, Muller SA. Follicular mucinosis: histopathologic review of 33 cases. Mayo Clin. Proc.66(4), 387–390 (1991).
   PubMed Web of Science ®Google Scholar
• Dawn G, Handa S, Kumar B. Follicular mucinosis and systemic lupus erythematosus. Dermatology195(2), 183–184 (1997).
   PubMedGoogle Scholar
• Hempstead RW, Ackerman AB. Follicular mucinosis. A reaction pattern in follicular epithelium. Am. J. Dermatopathol.7(3), 245–257 (1985).
   PubMed Web of Science ®Google Scholar
• Jonelis FJ. Simultaneous occurrence of Goodpasture’s syndrome and follicular mucinosis. Arch. Dermatol.113(8), 1129 (1977).
   PubMedGoogle Scholar
• Boer A, Guo Y, Ackerman AB. Alopecia mucinosa is mycosis fungoides. Am. J. Dermatopathol.26(1), 33–52 (2004).
   PubMed Web of Science ®Google Scholar
• Jackow CM, Papadopoulos E, Nelson B, Tschen JA, Heatherington G, Duvic M. Follicular mucinosis associated with scarring alopecia, oligoclonal T-cell receptor V β expansion, and Staphylococcus aureus: when does follicular mucinosis become mycosis fungoides? J. Am. Acad. Dermatol.37(5 Pt 2), 828–831 (1997).
   PubMed Web of Science ®Google Scholar
• Dalle S, Balme B, Berger F, Hayette S, Thomas L. Mycosis fungoides-associated follicular mucinosis under adalimumab. Br. J. Dermatol.153(1), 207–208 (2005).
   PubMed Web of Science ®Google Scholar
• Yanagi T, Sawamura D, Shimizu H. Follicular mucinosis associated with imatinib (STI571). Br. J. Dermatol.151(6), 1276–1278 (2004).
   PubMedGoogle Scholar
• van Doorn R, Scheffer E, Willemze R. Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients. Arch. Dermatol.138(2), 191–198 (2002).
   PubMedGoogle Scholar
• Emmerson RW. Follicular mucinosis. A study of 47 patients. Br. J. Dermatol.81(6), 395–413 (1969).
   PubMed Web of Science ®Google Scholar
• Matuska MA, Weigand DA. Anesthesia in alopecia mucinosa. Cutis40(1), 46–47 (1987).
   PubMed Web of Science ®Google Scholar
• Snyder RA, Crain WR, McNutt NS. Alopecia mucinosa. Report of a case with diffuse alopecia and normal-appearing scalp skin. Arch. Dermatol.120(4), 496–498 (1984).
   PubMedGoogle Scholar
• Ferreira-Marques J. Sensory imbalance in alopecia mucinosa. Arch. Dermatol.84, 302–305 (1961).
   PubMedGoogle Scholar
• Cerroni L, Fink-Puches R, Back B, Kerl H. Follicular mucinosis: a critical reappraisal of clinicopathologic features and association with mycosis fungoides and Sezary syndrome. Arch. Dermatol.138(2), 182–189 (2002).
   PubMedGoogle Scholar
• Somani N, Bergfeld WF. Cicatricial alopecia: classification and histopathology. Dermatol. Ther.21(4), 221–237 (2008).
   PubMed Web of Science ®Google Scholar
• Coskey RJ, Mehregan AH. Alopecia mucinosa. A follow-up study. Arch. Dermatol.102(2), 193–194 (1970).
   PubMedGoogle Scholar
• Lancer HA, Bronstein BR, Nakagawa H, Bhan AK, Mihm MC Jr. Follicular mucinosis: a detailed morphologic and immunopathologic study. J. Am. Acad. Dermatol.10(5 Pt 1), 760–768 (1984).
   PubMed Web of Science ®Google Scholar
• Anderson BE, Mackley CL, Helm KF. Alopecia mucinosa: report of a case and review. J. Cutan. Med. Surg.7(2), 124–128 (2003).
   PubMed Web of Science ®Google Scholar
• Arca E, Kose O, Tastan HB, Gur AR, Safali M. Follicular mucinosis responding to isotretinoin treatment. J. Dermatolog. Treat.15(6), 391–395 (2004).
   PubMedGoogle Scholar
• Harthi FA, Kudwah A, Ajlan A, Nuaim A, Shehri F. Urticaria-like follicular mucinosis responding to dapsone. Acta Derm. Venereol.83(5), 389–390 (2003).
   PubMed Web of Science ®Google Scholar
• Kodama H, Umemura S, Nohara N. Follicular mucinosis: response to indomethacin. J. Dermatol.15(1), 72–75 (1988).
   PubMedGoogle Scholar
• Apisarnthanarax N, Ha CS, Duvic M. Mycosis fungoides with follicular mucinosis displaying aggressive tumor-stage transformation : successful treatment using radiation therapy plus oral bexarotene combination therapy. Am. J. Clin. Dermatol.4(6), 429–433 (2003).
   PubMed Web of Science ®Google Scholar
• von Kobyletzki G, Kreuter JA, Nordmeier R, Stucker M, Altmeyer P. Treatment of idiopathic mucinosis follicularis with UVA1 cold light phototherapy. Dermatology201(1), 76–77 (2000).
   PubMed Web of Science ®Google Scholar
• Wittenberg GP, Gibson LE, Pittelkow MR, el-Azhary RA. Follicular mucinosis presenting as an acneiform eruption: report of four cases. J. Am. Acad. Dermatol.38(5 Pt 2), 849–851 (1998).
   PubMed Web of Science ®Google Scholar
• Kontochristopoulos GJ, Exadaktylou D, Hatziolou E, Tassidou A, Zakopoulou N. Follicular mucinosis associated with early stage cutaneous T-cell lymphoma: successful treatment with interferon α-2b and acitretin. J. Dermatolog. Treat.12(2), 117–121 (2001).
   PubMed Web of Science ®Google Scholar
• Meissner K, Weyer U, Kowalzick L, Altenhoff J. Successful treatment of primary progressive follicular mucinosis with interferons. J. Am. Acad. Dermatol.24(5 Pt 2), 848–850 (1991).
   PubMed Web of Science ®Google Scholar
• Baden HP, Byers HR. Clinical findings, cutaneous pathology, and response to therapy in 21 patients with keratosis pilaris atrophicans. Arch. Dermatol.130(4), 469–475 (1994).
   PubMedGoogle Scholar
• Bellet JS, Kaplan AL, Selim MA, Olsen EA. Keratosis follicularis spinulosa decalvans in a family. J. Am. Acad. Dermatol.58(3), 499–502 (2008).
   PubMed Web of Science ®Google Scholar
• Porteous ME, Strain L, Logie LJ, Herd RM, Benton EC. Keratosis follicularis spinulosa decalvans: confirmation of linkage to Xp22.13-p22.2. J. Med. Genet.35(4), 336–337 (1998).
   PubMed Web of Science ®Google Scholar
• Gimelli G, Giglio S, Zuffardi O et al. Gene dosage of the spermidine/spermine N(1)-acetyltransferase (SSAT) gene with putrescine accumulation in a patient with a Xp21.1p22.12 duplication and keratosis follicularis spinulosa decalvans (KFSD). Hum. Genet.111(3), 235–241 (2002).
   PubMed Web of Science ®Google Scholar
• Castori M, Covaciu C, Paradisi M, Zambruno G. Clinical and genetic heterogeneity in keratosis follicularis spinulosa decalvans. Eur. J. Med. Genet.52(1), 53–58 (2009).
   PubMed Web of Science ®Google Scholar
• van Osch LD, Oranje AP, Keukens FM, van Voorst Vader PC, Veldman E. Keratosis follicularis spinulosa decalvans: a family study of seven male cases and six female carriers. J. Med. Genet.29(1), 36–40 (1992).
   PubMed Web of Science ®Google Scholar
• Herd RM, Benton EC. Keratosis follicularis spinulosa decalvans: report of a new pedigree. Br. J. Dermatol.134(1), 138–142 (1996).
   PubMed Web of Science ®Google Scholar
• Rand R, Baden HP. Keratosis follicularis spinulosa decalvans. Report of two cases and literature review. Arch. Dermatol.119(1), 22–26 (1983).
   PubMedGoogle Scholar
• Richard G, Harth W. [Keratosis follicularis spinulosa decalvans. Therapy with isotretinoin and etretinate in the inflammatory stage.] Hautarzt44(8), 529–534 (1993).
   PubMed Web of Science ®Google Scholar
• Brooke RC, Griffiths CE. Folliculitis decalvans. Clin. Exp. Dermatol.26(1), 120–122 (2001).
   PubMed Web of Science ®Google Scholar
• Fernandes JC, Correia TM, Azevedo F, Mesquita-Guimaraes J. Tufted hair folliculitis after scalp injury. Cutis67(3), 243–245 (2001).
   PubMed Web of Science ®Google Scholar
• Chiarini C, Torchia D, Bianchi B, Volpi W, Caproni M, Fabbri P. Immunopathogenesis of folliculitis decalvans: clues in early lesions. Am. J. Clin. Pathol.130(4), 526–534 (2008).
   PubMed Web of Science ®Google Scholar
• Annessi G. Tufted folliculitis of the scalp: a distinctive clinicohistological variant of folliculitis decalvans. Br. J. Dermatol.138(5), 799–805 (1998).
   PubMed Web of Science ®Google Scholar
• Powell J, Dawber RP. Folliculitis decalvans and tufted folliculitis are specific infective diseases that may lead to scarring, but are not a subset of central centrifugal scarring alopecia. Arch. Dermatol.137(3), 373–374 (2001).
   PubMedGoogle Scholar
• Janjua SA, Iftikhar N, Pastar Z, Hosler GA. Keratosis follicularis spinulosa decalvans associated with acne keloidalis nuchae and tufted hair folliculitis. Am. J. Clin. Dermatol.9(2), 137–140 (2008).
   PubMed Web of Science ®Google Scholar
• Chandrawansa PH, Giam YC. Folliculitis decalvans – a retrospective study in a tertiary referred centre, over five years. Singapore Med. J.44(2), 84–87 (2003).
   PubMedGoogle Scholar
• Abeck D, Korting HC, Braun-Falco O. Folliculitis decalvans. Long-lasting response to combined therapy with fusidic acid and zinc. Acta Derm. Venereol.72(2), 143–145 (1992).
   PubMed Web of Science ®Google Scholar
• Powell JJ, Dawber RP, Gatter K. Folliculitis decalvans including tufted folliculitis: clinical, histological and therapeutic findings. Br. J. Dermatol.140(2), 328–333 (1999).
   PubMed Web of Science ®Google Scholar
• Brozena SJ, Cohen LE, Fenske NA. Folliculitis decalvans – response to rifampin. Cutis42(6), 512–515 (1988).
   PubMed Web of Science ®Google Scholar
• Paquet P, Pierard GE. [Dapsone treatment of folliculitis decalvans]. Ann. Dermatol. Venereol.131(2), 195–197(2004).
   PubMed Web of Science ®Google Scholar
• Gemmeke A, Wollina U. Folliculitis decalvans of the scalp: response to triple therapy with isotretinoin, clindamycin, and prednisolone. Acta Dermatovenerol. Alp. Panonica Adriat.15(4), 184–186 (2006).
   PubMedGoogle Scholar
• Salinger D. Treatment of folliculitis decalvans with tyrosine. Exp. Dermatol.8(4), 363–364 (1999).
   PubMedGoogle Scholar
• Goo B, Chung HJ, Chung WG, Chung KY. Intramuscular immunoglobulin for recalcitrant suppurative diseases of the skin: a retrospective review of 63 cases. Br. J. Dermatol.157(3), 563–568 (2007).
   PubMed Web of Science ®Google Scholar
• Parlette EC, Kroeger N, Ross EV. Nd:YAG laser treatment of recalcitrant folliculitis decalvans. Dermatol. Surg.30(8), 1152–1154 (2004).
   PubMed Web of Science ®Google Scholar
• Walker SL, Smith HR, Lun K, Griffiths WA. Improvement of folliculitis decalvans following shaving of the scalp. Br. J. Dermatol.142(6), 1245–1246 (2000).
   PubMed Web of Science ®Google Scholar
• Stites PC, Boyd AS. Dissecting cellulitis in a white male: a case report and review of the literature. Cutis67(1), 37–40 (2001).
   PubMed Web of Science ®Google Scholar
• Moyer DG, Williams RM. Perifolliculitis capitis abscedens et suffodiens. A report of six cases. Arch. Dermatol.85, 378–384 (1962).
   PubMedGoogle Scholar
• Scheinfeld NS. A case of dissecting cellulitis and a review of the literature. Dermatol. Online J.9(1), 8 (2003).
   PubMedGoogle Scholar
• McMullan FH, Zeligman I. Perifolliculitis capitis abscedens et suffodiens; its successful treatment with x-ray epilation. AMA Arch. Derm.73(3), 256–263 (1956).
   PubMedGoogle Scholar
• Salim A, David J, Holder J. Dissecting cellulitis of the scalp with associated spondylarthropathy: case report and review. J. Eur. Acad. Dermatol. Venereol.17(6), 689–691 (2003).
   PubMed Web of Science ®Google Scholar
• Libow LF, Friar DA. Arthropathy associated with cystic acne, hidradenitis suppurativa, and perifolliculitis capitis abscedens et suffodiens: treatment with isotretinoin. Cutis64(2), 87–90 (1999).
   PubMed Web of Science ®Google Scholar
• Ongchi DR, Fleming MG, Harris CA. Sternocostoclavicular hyperostosis: two cases with differing dermatologic syndromes. J. Rheumatol.17(10), 1415–1418 (1990).
   PubMed Web of Science ®Google Scholar
• Ramasastry SS, Granick MS, Boyd JB, Futrell JW. Severe perifolliculitis capitis with osteomyelitis. Ann. Plast. Surg.18(3), 241–244 (1987).
   PubMed Web of Science ®Google Scholar
• Sivakumaran S, Meyer P, Burrows NP. Dissecting folliculitis of the scalp with marginal keratitis. Clin. Exp. Dermatol.26(6), 490–492 (2001).
   PubMed Web of Science ®Google Scholar
• Boyd AS, Zemtsov A. A case of pyoderma vegetans and the follicular occlusion triad. J. Dermatol.19(1), 61–63 (1992).
   PubMedGoogle Scholar
• Curry SS, Gaither DH, King LE Jr. Squamous cell carcinoma arising in dissecting perifolliculitis of the scalp. A case report and review of secondary squamous cell carcinomas. J. Am. Acad. Dermatol.4(6), 673–678 (1981).
   PubMed Web of Science ®Google Scholar
• Solomon AR. The transversely sectioned scalp biopsy specimen: the technique and an algorithm for its use in the diagnosis of alopecia. Adv. Dermatol.9, 127–157 (1994).
   PubMedGoogle Scholar
• Newton RC, Hebert AA, Freese TW, Solomon AR. Scarring alopecia. Dermatol. Clin.5(3), 603–618 (1987).
   PubMed Web of Science ®Google Scholar
• Sellheyer K, Bergfeld WF. Histopathologic evaluation of alopecias. Am. J. Dermatopathol.28(3), 236–259 (2006).
   PubMed Web of Science ®Google Scholar
• Schewach-Millet M, Ziv R, Shapira D. Perifolliculitis capitis abscedens et suffodiens treated with isotretinoin (13-cis-retinoic acid). J. Am. Acad. Dermatol.15(6), 1291–1292 (1986).
   PubMed Web of Science ®Google Scholar
• Khaled A, Zeglaoui F, Zoghlami A, Fazaa B, Kamoun MR. Dissecting cellulitis of the scalp: response to isotretinoin. J. Eur. Acad. Dermatol. Venereol.21(10), 1430–1431 (2007).
   PubMed Web of Science ®Google Scholar
• Jolliffe DS, Sarkany I. Perifolliculitis capitis abscedens et suffoidiens (dissecting cellulitis of the scalp). Clin. Exp. Dermatol.2(3), 291–293 (1977).
   PubMed Web of Science ®Google Scholar
• Halder RM. Hair and scalp disorders in blacks. Cutis32(4), 378–380 (1983).
   PubMed Web of Science ®Google Scholar
• Boyd AS, Binhlam JQ. Use of an 800-nm pulsed-diode laser in the treatment of recalcitrant dissecting cellulitis of the scalp. Arch. Dermatol.138(10), 1291–1293 (2002).
   PubMedGoogle Scholar
• Kobayashi H, Aiba S, Tagami H. Successful treatment of dissecting cellulitis and acne conglobata with oral zinc. Br. J. Dermatol.141(6), 1137–1138 (1999).
   PubMed Web of Science ®Google Scholar
• Chinnaiyan P, Tena LB, Brenner MJ, Welsh JS. Modern external beam radiation therapy for refractory dissecting cellulitis of the scalp. Br. J. Dermatol.152(4), 777–779 (2005).
   PubMed Web of Science ®Google Scholar
• Krasner BD, Hamzavi FH, Murakawa GJ, Hamzavi IH. Dissecting cellulitis treated with the long-pulsed Nd:YAG laser. Dermatol. Surg.32(8), 1039–1044 (2006).
   PubMed Web of Science ®Google Scholar
• Knable AL, Jr., Hanke CW, Gonin R. Prevalence of acne keloidalis nuchae in football players. J. Am. Acad. Dermatol.37(4), 570–574 (1997).
   PubMed Web of Science ®Google Scholar
• Sperling LC, Homoky C, Pratt L, Sau P. Acne keloidalis is a form of primary scarring alopecia. Arch. Dermatol.136(4), 479–484 (2000).
   PubMedGoogle Scholar
• Burkhart CG, Burkhart CN. Acne keloidalis is lichen simplex chronicus with fibrotic keloidal scarring. J. Am. Acad. Dermatol.39(4 Pt 1), 661 (1998).
   PubMedGoogle Scholar
• Kantor GR, Ratz JL, Wheeland RG. Treatment of acne keloidalis nuchae with carbon dioxide laser. J. Am. Acad. Dermatol.14(2 Pt 1), 263–267 (1986).
   PubMed Web of Science ®Google Scholar
• Luz Ramos M, Munoz-Perez MA, Pons A, Ortega M, Camacho F. Acne keloidalis nuchae and tufted hair folliculitis. Dermatology194(1), 71–73 (1997).
   PubMed Web of Science ®Google Scholar
• Carnero L, Silvestre JF, Guijarro J, Albares MP, Botella R. Nuchal acne keloidalis associated with cyclosporin. Br. J. Dermatol.144(2), 429–430 (2001).
   PubMed Web of Science ®Google Scholar
• Azurdia RM, Graham RM, Weismann K, Guerin DM, Parslew R. Acne keloidalis in caucasian patients on cyclosporin following organ transplantation. Br. J. Dermatol.143(2), 465–467 (2000).
   PubMed Web of Science ®Google Scholar
• Grunwald MH, Ben-Dor D, Livni E, Halevy S. Acne keloidalis-like lesions on the scalp associated with antiepileptic drugs. Int. J. Dermatol.29(8), 559–561 (1990).
   PubMed Web of Science ®Google Scholar
• Dinehart SM, Herzberg AJ, Kerns BJ, Pollack SV. Acne keloidalis: a review. J. Dermatol. Surg. Oncol.15(6), 642–647 (1989).
   PubMedGoogle Scholar
• Goette DK, Berger TG. Acne keloidalis nuchae. A transepithelial elimination disorder. Int. J. Dermatol.26(7), 442–444 (1987).
   PubMed Web of Science ®Google Scholar
• Herzberg AJ, Dinehart SM, Kerns BJ, Pollack SV. Acne keloidalis. Transverse microscopy, immunohistochemistry, and electron microscopy. Am. J. Dermatopathol.12(2), 109–121 (1990).
   PubMed Web of Science ®Google Scholar
• Callender VD, Young CM, Haverstock CL, Carroll CL, Feldman SR. An open label study of clobetasol propionate 0.05% and bmethasone valerate 0.12% foams in the treatment of mild to moderate acne keloidalis. Cutis75(6), 317–321 (2005).
   PubMed Web of Science ®Google Scholar
• Mahe A. [Treatment of acne keloidalis nuchae: recommendations.] Ann. Dermatol. Venereol.126(6–7), 541–542 (1999).
   PubMed Web of Science ®Google Scholar
• Dinehart SM, Tanner L, Mallory SB, Herzberg AJ. Acne keloidalis in women. Cutis44(3), 250–252 (1989).
   PubMed Web of Science ®Google Scholar
• Gloster HM Jr. The surgical management of extensive cases of acne keloidalis nuchae. Arch. Dermatol.136(11), 1376–1379 (2000).
   PubMedGoogle Scholar
• Bajaj V, Langtry JA. Surgical excision of acne keloidalis nuchae with secondary intention healing. Clin. Exp. Dermatol.33(1), 53–55 (2008).
   PubMed Web of Science ®Google Scholar
• Stritzler C, Friedman R, Loveman AB. Acne necrotica; relation to acne necrotica miliaris and response to penicillin and other antibiotics. AMA Arch. Derm. Syphilol.64(4), 464–469 (1951).
   PubMedGoogle Scholar
• Kossard S, Collins A, McCrossin I. Necrotizing lymphocytic folliculitis: the early lesion of acne necrotica (varioliformis). J. Am. Acad. Dermatol.16(5 Pt 1), 1007–1014 (1987).
   PubMed Web of Science ®Google Scholar
• Fisher DA. Acne necroticans (varioliformis) and Staphylococcus aureus. J. Am. Acad. Dermatol.18(5 Pt 1), 1136–1138 (1988).
   PubMed Web of Science ®Google Scholar
• Maibach HI. Acne necroticans (varioliformis) versus Propionibacterium acnes folliculitis. J. Am. Acad. Dermatol.21(2 Pt 1), 323 (1989).
   PubMedGoogle Scholar
• Milde P, Goerz G, Plewig G. [Acne necrotica (varioliformis). Necrotizing lymphocytic folliculitis]. Hautarzt44(1), 34–36 (1993).
   PubMed Web of Science ®Google Scholar
• Zirn JR, Scott RA, Hambrick GW. Chronic acneiform eruption with crateriform scars. Acne necrotica (varioliformis) (necrotizing lymphocytic folliculitis). Arch. Dermatol.132(11), 1367–1370 (1996).
   PubMedGoogle Scholar
• Kalamkarian AA, Chistiakova IA, Zabanova EV. [Acne necrotica.] Vestn. Dermatol. Venerol. (2), 25–28 (1990).
   PubMedGoogle Scholar
• Caputo R, Veraldi S. Erosive pustular dermatosis of the scalp. J. Am. Acad. Dermatol.28(1), 96–98 (1993).
   PubMed Web of Science ®Google Scholar
• Grattan CE, Peachey RD, Boon A. Evidence for a role of local trauma in the pathogenesis of erosive pustular dermatosis of the scalp. Clin. Exp. Dermatol.13(1), 7–10 (1988).
   PubMed Web of Science ®Google Scholar
• Mehmi M, Abdullah A. Erosive pustular dermatosis of the scalp occurring after partial thickness skin graft for squamous cell carcinoma. Br. J. Plast. Surg.57(8), 806–807 (2004).
   PubMedGoogle Scholar
• Drouin CA, Cloutier RA. [Recurrence of erosive pustular scalp dermatosis after a skin graft.] Ann. Dermatol. Venereol.126(4), 335–338 (1999).
   PubMed Web of Science ®Google Scholar
• Wollenberg A, Heckmann M, Braun-Falco O. [Erosive pustular dermatosis of the scalp after zoster ophthalmicus and trauma]. Hautarzt43(9), 576–579 (1992).
   PubMed Web of Science ®Google Scholar
• Trueb RM, Krasovec M. Erosive pustular dermatosis of the scalp following radiation therapy for solar keratoses. Br. J. Dermatol.141(4), 763–765 (1999).
   PubMedGoogle Scholar
• Rongioletti F, Delmonte S, Rossi ME, Strani GF, Rebora A. Erosive pustular dermatosis of the scalp following cryotherapy and topical tretinoin for actinic keratoses. Clin. Exp. Dermatol.24(6), 499–500 (1999).
   PubMed Web of Science ®Google Scholar
• Patton D, Lynch PJ, Fung MA, Fazel N. Chronic atrophic erosive dermatosis of the scalp and extremities: a recharacterization of erosive pustular dermatosis. J. Am. Acad. Dermatol.57(3), 421–427 (2007).
   PubMed Web of Science ®Google Scholar
• Pye RJ, Peachey RD, Burton JL. Erosive pustular dermatosis of the scalp. Br. J. Dermatol.100(5), 559–566 (1979).
   PubMed Web of Science ®Google Scholar
• Burton JL, Peachey RD, Pye RJ. Erosive pustular dermatosis of the scalp – a definition. Br. J. Dermatol.119(3), 411 (1988).
   PubMed Web of Science ®Google Scholar
• Boffa MJ. Erosive pustular dermatosis of the scalp successfully treated with calcipotriol cream. Br. J. Dermatol.148(3), 593–595 (2003).
   PubMedGoogle Scholar
• Seez M, Rodriguez-Martin M, Sidro M, Carnerero A, Garcia-Bustinduy M, Noda A. Successful treatment of erosive pustular dermatosis of the scalp with topical tacrolimus. Clin. Exp. Dermatol.30(5), 599–600 (2005).
   PubMed Web of Science ®Google Scholar